News bulletins on arthritis change topic search help Biologic Agents For The Treatment Of Rheumatoid Arthritis Are Used By Less Than Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that although biolo...... more info | broken? | rate | 10 January 2007 Phytomedics' Novel Oral Disease Modifying Drug Candidate PMI-001 Demonstrat Phytomedics Inc., a biopharmaceutical company merging human health care and plant biotechnology to discover, develop and manufacture novel botanical t...... more info | broken? | rate | 10 January 2007 Fatigue Reduced In Auto-Immune Conditions By Low Impact Aerobic Exercise Sa Low impact aerobic exercise, such as walking and cycling, can effectively reduce fatigue in adults with chronic auto-immune conditions, according ...... more info | broken? | rate | 10 January 2007 FDA Advisory Committee Recommends Approval Of Celebrex For Use In Children An FDA advisory panel on Wednesday voted 15-1 to recommend approval of Pfizer's pain medication Celebrex for the treatment of rheumatoid arthritis...... more info | broken? | rate | 10 January 2007 Nastech Pharmaceutical Company Inc. Provides Update On Parathyroid Hormone (PTH Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) today provided a progress report on the significant clinical development program currently being co...... more info | broken? | rate | 10 January 2007 Genmab Announces Positive Interim Data For The HuMax-CD20 Phase II RA Study Genmab A/S (CSE: GEN) announced today positive results from an interim analysis of the first 100 patients in the ongoing Phase II rheumatoid arthritis...... more info | broken? | rate | 10 January 2007 Immune Cells Get Together In The Lung Of Patients With Rheumatoid Arthritis Cells of the immune system congregate at various sites throughout the body, and it is at these sites that they become primed to respond to invading mi...... more info | broken? | rate | 10 January 2007 Osteologix Initiates Phase II Clinical Trial Of Investigational Drug For Osteop Osteologix Inc. (OTC Bulletin Board: OLGX) announced today that it has initiated a randomized, double-blind, placebo-controlled phase II clini...... more info | broken? | rate | 10 January 2007 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Get the arthritis feed (what is this?) © 2006 Jemdam LLP Terms & Legals | webmasters click to add your feed | free magic tricks | magic tricks | buy sell downloads